ANH-USA worked closely with our allies in the senate to ensure that dietary supplements are protected from Codex language in the Senate Food Safety bill.
Next week the title of our newsletter will change, but the focus will remain unchanged.
Human beings cannot live without vitamin B-6. The FDA recently gave one natural form of this critical vitamin to a drug company for its exclusive use. Another drug company wants the most important natural form as well, the one that our bodies cannot do without. Please help stop this outrageous vitamin grab.
The Food and Drug Administration has disregarded government experts sounding the alarm about routine exposure to medical radiation, including the powerful CT scans used to screen for colon cancer. This is yet another example of why fundamental FDA reform remains so important.
Acetaminophen (e.g. Tylenol) is linked to 50 percent of all liver failure in the United States. It can also cause eye disease, asthma, hearing loss — and death. Why is the FDA silent about the dangers of this country’s most commonly used painkiller?
The reexamination of a knee device and a campaign to extend the patent of a blood-thinning medication underscore the need for FDA reform.
Evidence mounts that many of the procedures that constitute the current “standard of care” fail to promote health, are unnecessary and may put patients at greater risk. These risks increase with a standardized, one-size-fits-all form of monopoly medicine.
Sens. Charles Grassley, I-Iowa, and Max Baucus, D-Mont., have released an October 2008 memo written by FDA drug-safety reviewers Drs. David Graham and Kate Gelperin. The memo concludes that Avandia poses serious risks exceeding those of Actos, a competing drug.
Two fourth-year Harvard Medical School students question the slow trickledown to medical schools from the 1999 Institute of Medicine report blaming medical errors for 98,000 deaths annually.
It’s paradoxical that our healthcare system, which excels at saving lives, can’t seem to cure itself of squandering money. A landmark comparative effectiveness study suggests ways to improve care and reduce waste — but appears to be ignored